GSK Eyes Limiting Natural Claim For Benefiber Following Industry Self-Regulation Ad Review
BBB National Programs' appellate panel finds GSK supports “helps you feel fuller longer” claim but not “clinically proven to curb cravings” for Benefiber supplements. GSK will comply with recommendation to pull "100% natural claim" but notes the panel recognized it “can make a more limited or qualified ‘natural’ claim that is supported by the evidence."
You may also be interested in...
NAD recommends qualifying Zarbee’s Naturals brand on packaging when a formulation contains synthetic ingredients. J&J business will comply but disagrees its brand is misleading and says the recommendation is “not based on empirical data from consumers surveys” but NAD attorneys’ intuition.
Revision to FDA's September 2020 guidance on assessing nitrosamine impurity risks associated with all chemically synthesized APIs and all approved drug products that contain those APIs doesn’t satisfy industry stakeholders.
Executives say Bausch + Lomb spin-out preparations will be completed by the end of Q3. When asked, they elaborated on Carl Icahn’s acquisition of 27.8m shares, for a 7.8% stake, and expansion of the firm’s board by two seats for Icahn’s representatives.